Structured JSON API for this factor page: https://sharemaestro.com/factors/api/tickers/07014ed0-2748-4c62-a19c-79d5ce39fb04/

ANTHEM

ANTHEM BIOSCIENCES LTD
Chart
₹761.50
Latest Week 2026-06-05
HealthcareBiotechnologyMEGA
Snapshot 2026-06-07 · 0.0w · Fresh
0.3
OS Score
3.0%
Value
98.0%
Quality
61.0%
Momentum
7/9
F-Score
0.171
QV
StrategiesValueQualityMomentumCompositeInteractionsFactor AnalysisTrendsFundamentals
Strategy Eligibility
0 of 23 passing
★
OS Composite
✗
↗
Trending Value
✗
◆
Quality × Value
✗
🏛
Cornerstone Value
✗
🌿
Cornerstone Growth
✗
💎
Deep Value
✗
◇
VC2 Cheapest
✗
📐
EBITDA/EV
✗
◐
Veiled Value
✗
▣
Piotroski Bargains
✗
🔬
Quality Compounders
✗
📈
Consistent Earners
✗
🌱
GARP
✗
🔄
Shareholder Yield
✗
💰
High Yield
✗
🚀
Momentum Leaders
✗
◉
Market Leaders
✗
◎
Tiny Titans
✗
🔍
Small Cap Value
✗
🛡
Low Volatility
✗
🏷
Sector Cheapest
✗
🧠
Capital Allocators
✗
⚡
Risk-Adj Momentum
✗
V
Value Analysis
Cheapness relative to fundamentals
3.0%ile
P/E
79.4×
P/S
20.7×
P/B
14.1×
E/P
0.0126
FCF Yield
0.015
EBITDA/EV
0.023
SH Yield
-0.001
Relative Strength Across Value Dimensions
Multiples & Yields — Decomposition
VC1 (5-Factor)
98.00000000
/100 — 1=cheapest
VC2 (Trending Value)
99.00000000
/100
VC3 (Buyback)
99.00000000
/100
P/E of 79.4x is premium-priced — the market is paying up for expected growth. VC2 score of 99.00000000/100 — expensive across all six composite measures.
Q
Quality Analysis
Profitability, efficiency, balance sheet & earnings quality
98.0%ile
ROE
0.177
ROA
0.157
Net Margin
0.261
Op Margin
0.338
GPA
0.382
Current
5.54
F-Score
7/9
Quality Radar — Relative Strength
Profitability & Leverage Breakdown
Rev Growth
0.152
Earn Growth
0.311
Stability
0.359
lower=better
Accruals
-0.089
lower=better
5yr Consist
No
M
Momentum & Risk
Price trend, volatility regime, risk-adjusted returns
61.0%ile
6M Return
16.4%
Vol 252d
32.5%
Vol 60d
69.7%
↑ Expanding
Max DD 12M
-29.2%
Return Comparison — 6M / 12M / 12-1
Volatility Regime — 60d vs 252d
Near-term vol (70%) is expanding vs long-term (33%) — risk is increasing.
OS
Composite & Factor Heatmap
All factors at a glance
0.3
Pillar Balance — Value / Quality / Momentum
Factor Heatmap — green=strong, red=weak
▦
Sector Context
Healthcare · 160 peers
Sector Value %ile
8.7%
Sector Quality %ile
98.1%
P/E z-score
-0.02
P/B z-score
1.80
Sector Avg OS
43.8%
Ticker vs Sector Averages
Relative Valuation Z-Score
Top Sector Peers (By OS)
SymbolNameOSValueQualityMomentum
NATCOPHARM NATCO Pharma Limited 98.0% 88.0% 87.0% 81.0%
LINCOLN Lincoln Pharmaceuticals Limited 97.0% 88.0% 80.0% 81.0%
UNIVPHOTO Universus Photo Imagings Limited 97.0% 86.0% 74.0% 94.0%
STAR Strides Pharma Science Limited 96.0% 73.0% 91.0% 91.0%
VENUSREM Venus Remedies Limited 96.0% 68.0% 94.0% 99.0%
HALEOSLABS Haleos Labs Limited 95.0% 82.0% 77.0% 81.0%
AUROPHARMA Aurobindo Pharma Limited 94.0% 71.0% 84.0% 87.0%
SPARC Sun Pharma Advanced Research Company Limited 93.0% 72.0% 86.0% 83.0%
Factor Interactions
Quality at a Premium
High quality (98th) but expensive (3th value). Upside may be limited without earnings growth.
Volatility Expanding
60-day vol (70%) significantly exceeds 252-day (33%). Near-term risk is elevated.
⚖
Factor Analysis
Comprehensive factor intelligence — strengths, weaknesses & cross-factor profile
Value
F
7.9% avg (7 factors)
Quality
A
85.9% avg (7 factors)
Momentum
C
57.9% avg (1 factors)
Risk
B
62.5% avg (1 factors)
High quality business commanding a premium price. The market recognises the quality — returns from here depend on continued fundamental execution.
▲ Top Strengths — highest scoring factors
▼ Key Weaknesses — lowest scoring factors
Factor Persistence1 snapshots
FactorCurrentStreakTrendSpark
OS Composite0.300—1—
Value %ile0.030—1—
Quality %ile0.980—1—
Momentum %ile0.610—0—
F-Score7.000—1—
Confidence0.879—1—
Volatility0.325—0—
Value FactorsCheapness relative to fundamentals — lower multiples = cheaper
P/E Ratio
79.41
Earnings Yield (E/P)
0.0126
Price / Sales
20.69
Price / Book
14.06
Price / Cash Flow
50.65
FCF Yield
1.5%
EBITDA / EV
2.3%
Sales Yield (1/P·S)
0.0486
Shareholder Yield
Div + net buyback / mktcap
-0.1%
Quality FactorsProfitability, efficiency, and balance sheet strength
Return on Equity
17.7%
Return on Assets
15.7%
Net Margin
26.1%
Operating Margin
33.8%
Gross Profit / Assets
Novy-Marx GPA
38.2%
Current Ratio
5.54
Accruals Ratio
(NI-OCF)/Assets — lower=better
-0.089
MomentumPrice trend strength over different horizons
6M Return
16.4%
Growth & StabilityEarnings trajectory, consistency, and capital allocation
Revenue Growth (YoY)
15.2%
Earnings Growth (YoY)
31.1%
Earnings Stability (CV)
Lower = more stable
0.359
5yr Consistent
EPS up every year for 5 years
No
Piotroski F-Score
7
Dividend Yield
0.0%
Buyback Yield
-0.1%
O'Shaughnessy CompositesValue Composites (WWOWS 4th Ed) — 1=cheapest, 100=most expensive
VC1 (5-factor)
P/E+P/S+P/B+P/CF+EBITDA/EV
98
VC2 (6-factor)
VC1 + Shareholder Yield — used for Trending Value
99
VC3 (6-factor)
VC1 + Buyback Yield — no dividend preference
99
Capital Allocation & AlphaAlpha within factors — quality of management decisions
Veiled Value
Expensive by P/B, cheap by everything else
No
Market Leader
Above-avg mcap+revenue, non-utility
No
All Stocks Universe
Market cap > $200M
Yes
Tiny Titan
Micro-cap, low P/S, positive momentum
No
Quarterly Fundamentals
Revenue
Net Income
FCF
Net Margin
Show all
Op Income
OCF
CapEx
Equity
Annual Fundamentals
Revenue
Net Income
FCF
Net Margin
Show all
Op Income
OCF
CapEx
Equity